Company filings profile · CIK 0001710340
Eton Pharmaceuticals, Inc. — SEC filings & insider activity.
Real, source-linked SEC EDGAR activity for Eton Pharmaceuticals, Inc. (ETON): 29 filings in the last 90 days vs 22 in the prior 90 (filing-velocity rising ↑ · 1.32×). Latest material 8-K events, insider Form-4 transactions, and periodic reports — monitored for change.
✔ Verified against the public SEC EDGAR filing record as of Sep 29, 2026. Source-linked, daily-refreshed.
Material 8-K events — Eton Pharmaceuticals, Inc.
8-K disclosures decoded by item code (the material events: agreements, results, control/management changes, impairments, restatements).
| Filed | Event | |
|---|---|---|
| Sep 28, 2026 | Other Events; Financial Statements and Exhibits | ↗ |
| Aug 13, 2026 | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Aug 5, 2026 | Entry into a Material Agreement; Completion of Acquisition/Disposition; Financial Statements and Exhibits | ↗ |
| Aug 4, 2026 | Departure/Election of Directors or Officers | ↗ |
| Jul 29, 2026 | Other Events; Financial Statements and Exhibits | ↗ |
| Jun 9, 2026 | Item 5.07 | ↗ |
Watch Eton Pharmaceuticals, Inc. automatically
Add this company to a watchlist and get a webhook/email the moment it files a material 8-K, an insider Form 4, or changes its risk-factor language.
Insider transactions (Form 4 / 3 / 5)
Recent filings
| Filed | Form | Detail | |
|---|---|---|---|
| Sep 28, 2026 | 8-K | Other Events; Financial Statements and Exhibits | ↗ |
| Aug 31, 2026 | 4/A | FORM 4/A | ↗ |
| Aug 28, 2026 | 4 | FORM 4 | ↗ |
| Aug 28, 2026 | 144 | ↗ | |
| Aug 24, 2026 | 4 | FORM 4 | ↗ |
| Aug 24, 2026 | 144 | ↗ | |
| Aug 20, 2026 | 4 | FORM 4 | ↗ |
| Aug 20, 2026 | 144/A | ↗ | |
| Aug 19, 2026 | 144 | ↗ | |
| Aug 13, 2026 | 10-Q | FORM 10-Q | ↗ |
| Aug 13, 2026 | 8-K | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Aug 12, 2026 | 3 | PRIMARY DOCUMENT | ↗ |
| Aug 5, 2026 | 8-K | Entry into a Material Agreement; Completion of Acquisition/Disposition; Financial Statements and Exhibits | ↗ |
| Aug 4, 2026 | 4 | FORM 4 | ↗ |
| Aug 4, 2026 | 4 | FORM 4 | ↗ |
| Aug 4, 2026 | 4 | FORM 4 | ↗ |
| Aug 4, 2026 | 4 | FORM 4 | ↗ |
| Aug 4, 2026 | 4 | FORM 4 | ↗ |
| Aug 4, 2026 | 4 | FORM 4 | ↗ |
| Aug 4, 2026 | 4 | FORM 4 | ↗ |
| Aug 4, 2026 | 4 | FORM 4 | ↗ |
| Aug 4, 2026 | 8-K | Departure/Election of Directors or Officers | ↗ |
| Jul 29, 2026 | 8-K | Other Events; Financial Statements and Exhibits | ↗ |
| Jul 28, 2026 | SCHEDULE 13G/A | ↗ | |
| Jul 17, 2026 | 4/A | ↗ | |
| Jul 16, 2026 | 4 | 4 | ↗ |
| Jul 14, 2026 | 4 | FORM 4 | ↗ |
| Jul 13, 2026 | 4 | FORM 4 | ↗ |
| Jul 7, 2026 | 4 | 4 | ↗ |
| Jun 30, 2026 | 4 | FORM 4 | ↗ |
| Jun 26, 2026 | 144 | ↗ | |
| Jun 25, 2026 | 144 | ↗ | |
| Jun 23, 2026 | 144 | ↗ | |
| Jun 17, 2026 | 4 | FORM 4 | ↗ |
| Jun 17, 2026 | 144 | ↗ | |
| Jun 9, 2026 | 8-K | Item 5.07 | ↗ |
| Jun 2, 2026 | 144 | ↗ | |
| Jun 1, 2026 | 3 | FORM 3 | ↗ |
| May 29, 2026 | 4 | FORM 4 | ↗ |
| May 28, 2026 | 144 | ↗ |